Ideación suicida en paciente a tratamiento con ombitasvir/ paritaprevir/ritonavir (Viekirax®), dasabuvir (Exviera®) y ribavirina (Rebetol®)
Fuente:
Redalyc
Saved in:
| Main Author: | |
|---|---|
| Format: | Artículo científico |
| Language: | es |
| Published: |
Sociedad Española de Farmacia Hospitalaria
2016
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
https://www.redalyc.org/articulo.oa?id=365964194011https://www.redalyc.org/journal/3659/365964194011/
https://www.redalyc.org/journal/3659/365964194011/html/
https://www.redalyc.org/journal/3659/365964194011/365964194011.epub
https://www.redalyc.org/journal/3659/365964194011/movil
https://doi.org/10.7399/fh.2016.40.5.10553